Maravai LifeSciences
(NASDAQ) MRVI
Maravai LifeSciences Financials at a Glance
Market Cap
$709.96M
Revenue (TTM)
$204.73M
Net Income (TTM)
$104.56M
EPS (TTM)
$-0.72
P/E Ratio
-6.71
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$4.88
Volume
1,271.327
Open
$4.39
Price
$4.88
Volume
1,271.327
Open
$4.39
Previous Close
$4.85
Daily Range
$4.36 - $4.95
52-Week Range
$1.95 - $4.95
Dividend
$0.00
Beta (Volatility)
1.13 (Average)
Price
$4.88
Volume
1,271.327
Open
$4.39
Previous Close
$4.85
Daily Range
$4.36 - $4.95
52-Week Range
$1.95 - $4.95
MRVI News
MRVI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Maravai LifeSciences
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
435
CEO
Bernd Brust
Website
www.maravai.comHeadquarters
San Diego, CA 92121, US
MRVI Financials
Key Financial Metrics (TTM)
Gross Margin
29%
Operating Margin
21%
Net Income Margin
-51%
Return on Equity
-41%
Return on Capital
6%
Return on Assets
-15%
Earnings Yield
-14.90%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$709.96M
Shares Outstanding
146.38M
Volume
1.27K
Avg. Volume
1.87M
Financials (TTM)
Gross Profit
$33.39M
Operating Income
$6.74M
EBITDA
$147.11M
Operating Cash Flow
$57.57M
Capital Expenditure
$13.15M
Free Cash Flow
$70.72M
Cash & ST Invst.
$216.89M
Total Debt
$35.58M
Maravai LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$65.84M
+40.5%
Gross Profit
$33.70M
+336.3%
Gross Margin
51.19%
N/A
Market Cap
$709.96M
N/A
Market Cap/Employee
$1.25M
N/A
Employees
570
N/A
Net Income
$3.73M
+87.5%
EBITDA
$2.16M
+93.0%
Quarterly Fundamentals
Net Cash
$130.61M
+252.6%
Accounts Receivable
$33.41M
+17.3%
Inventory
$40.46M
-18.7%
Long Term Debt
$29.87M
-91.8%
Short Term Debt
$5.44M
-13.3%
Return on Assets
-14.66%
N/A
Return on Invested Capital
6.43%
N/A
Free Cash Flow
$4.23M
+128.9%
Operating Cash Flow
$8.66M
+192.3%